Pune: Lokmanya Hospitals, Asia’s leader in robotic-assisted joint replacement surgery, has announced a major strategic expansion following a controlling investment by Unaprime Healthcare LLP, which has acquired an 84.5% stake in the healthcare group.
This transformational move aims to position Lokmanya Hospitals as Maharashtra’s leading multi-specialty and quaternary care hospital chain by 2029.
The investment includes the acquisition of Tata Healthcare Fund’s stake and a significant primary capital infusion, with further growth investments planned.
Also Read: CIVIE and Prime Healthcare Partner to Deploy AI-Powered Radiology Solutions
Backed by distinguished domestic limited partners and healthcare pioneers like Dr K Ravindranath and Manpreet Sohal, this strategic collaboration is set to redefine the state’s healthcare landscape.
Expanding Capacity and Clinical Excellence
Under the leadership of Group CEO & Managing Director Manpreet Sohal and Chairman Dr Narendra Vaidya, Lokmanya Hospitals will grow from 300+ to over 800 beds in the next 3–4 years. The plan includes launching world-class centres of excellence in:
Orthopaedics and Robotic Surgery
- Cardiac Sciences
- Neurosciences
- Cancer Care
- General and GI Surgery
- Multi-organ Transplantation
- Trauma and Critical Care
Lokmanya will continue to serve as a referral hub across Western India while capturing premium healthcare market segments through precision medicine and robotic-assisted technologies.
Manpreet Sohal, Group CEO & MD, Lokmanya Hospitals: “This partnership with Unaprime Healthcare marks a pivotal milestone in our journey. By blending our robotic surgery legacy with advanced multi-specialty care, we are building a healthcare platform that will deliver scalable, inclusive, and high-quality outcomes across Maharashtra.”
Dr Narendra Vaidya, Chairman: “Having pioneered robotic surgery in Asia, Lokmanya is now poised to extend this clinical leadership into a comprehensive, patient-first hospital network across Maharashtra and beyond.”
Deep Mishra, Founder, Unaprime Investment Advisors: “Lokmanya’s track record in robotics and joint replacement is unmatched. With this investment, we aim to elevate Lokmanya into a nationally recognized centre for multi-specialty excellence and innovation.”
Also Read: Quadria Group Launches $300M HealthQuad Fund III to Back Disruptive Healthcare Startups
Investment and Expansion Highlights:
- Stake Acquired: 84.5% by Unaprime Healthcare LLP
- Bed Expansion: From 300+ to 800+ beds within 3–4 years
- Geographic Reach: Four hospitals in Pune; expansion into Mumbai and Kolhapur
- Clinical Milestones: 150,000+ patients treated, 50,000+ knee replacements, 15,000+ robotic surgeries
About Lokmanya Hospitals
With a 50-year legacy and India’s first robotic knee replacement (2017), Lokmanya Hospitals is a recognized leader in orthopaedic care and robotic surgery. The group operates four hospitals in Pune and is expanding into Mumbai and Kolhapur. Under the vision of Dr. Narendra Vaidya, the hospital continues to pioneer advanced surgical technologies and deliver patient-centric outcomes.
About Unaprime Healthcare LLP
Unaprime Healthcare LLP is a Special Purpose Vehicle of Unaprime Investment Advisors, a healthcare-focused investment firm dedicated to scaling high-impact medical infrastructure across India. The firm partners with visionary healthcare leaders to deliver strategic, operational, and financial value in healthcare transformation.
